Pharmacology NSG 251 Exam 1 Questions With
Correct Answers
The |5 |steps |of |the |nursing |process |are?
Assessment, |Human |needs |statement, |Planning |(goals), |Implementation |(patient |teaching), |
Evaluation
Assessment
Data |is |collected, |reviewed |an |analyzed, |Head |to |toe |assessment, |vital |signs, |direct |and |
indirect |questioning, |medical |record |review, |observation, |obtaining |a |medication |profile |
(includes |both |prescription |and |OTC), |compliance |issues
Human |needs |statement
Focuses |on |how |the |data |collected |signifies |a |problem, |strength, |or |vulnerability
Human |needs |statement |example
Risk |for |injury |related |to |(R/T) |lack |of |experience |with |medication |regimen |and |second |grade |
reading |level |as |an |adult |as |evidence |by |(AEB) |inability |to |perform |a |return |demonstration |and
|inability |to |state |common |side |effects
Planning |(outcome |identification)
Outcomes |are |objective, |measurable, |and |realistic |with |an |established |time |period |for |
achievement |of |the |outcomes |that |are |specifically |stated |in |the |outcome |criteria
,Outcome |criteria |includes:
Concrete |descriptions |of |patient |goals, |Expectations |for |behavior, |For |drug |therapy: |our |
expected |outcome |is |safe |and |effective |administration |of |medications
Implementation
Requires |communication/collaboration |with |the |patient, |family, |and |healthcare |provider |team,
|consists |of |initiation |and |completion |of |nursing |actions |as |defined |by |the |Human |Needs |
Statements, |goals, |and |outcome |criteria
With |medication |administration?
you |must |be |knowledgeable |about |your |patient |and |the |medication |you |are |administering, |
and |the |medication |safety |rights
Evaluation
Ongoing |part |of |the |nursing |process, |Includes |monitoring |for |outcomes, |the |patient's |response
|to |drug |therapy |and |any |expected/unexpected |responses, |Documentation |is |important |and |
needs |to |be |clear |and |concise
6 |Rights |+ |3 |rights |of |medication |administration
Right |Client, |Right |medication, |Right |dosage, |Right |route, |Right |time, |Right |documentation |+ |
Right |to |refuse, |Right |indication, |and |Right |Response
, Generic |Name |(nonproprietary)
Usually |much |shorter |and |simpler |than |the |chemical |name. |Patientsoften |only |know |the |
generic |name.
Trade |name |(proprietary)
The |drug |has |a |registered |trademark |and |indicates |it |is |restricted |to |the |owner |of |the |patent |
for |the |drug, |Names |are |usually |shorter |and |easier |to |pronounce |remember |than |generic |
names
what |are |the |benefits |of |using |a |generic |drug?
it |is |cheaper |for |pharmacists |to |go |by |this |name |and |most |patients |know |this |name
Pharmaceutics
The |study |of |how |various |drug |forms |influence |the |way |in |which |the |drug |affects |the |body, |
Dosage |forms |include |enteral, |parenteral, |topical
Do |NOT |crush |drugs |that |have |what?
SR |(slow |released), |SA |(sustained |action), |CR |(controlled |release), |XL |(extended |length), |or |XT |
(extended |time) |they |are |extended-release |formulations
Pharmacokinetics |(4 |steps)
Correct Answers
The |5 |steps |of |the |nursing |process |are?
Assessment, |Human |needs |statement, |Planning |(goals), |Implementation |(patient |teaching), |
Evaluation
Assessment
Data |is |collected, |reviewed |an |analyzed, |Head |to |toe |assessment, |vital |signs, |direct |and |
indirect |questioning, |medical |record |review, |observation, |obtaining |a |medication |profile |
(includes |both |prescription |and |OTC), |compliance |issues
Human |needs |statement
Focuses |on |how |the |data |collected |signifies |a |problem, |strength, |or |vulnerability
Human |needs |statement |example
Risk |for |injury |related |to |(R/T) |lack |of |experience |with |medication |regimen |and |second |grade |
reading |level |as |an |adult |as |evidence |by |(AEB) |inability |to |perform |a |return |demonstration |and
|inability |to |state |common |side |effects
Planning |(outcome |identification)
Outcomes |are |objective, |measurable, |and |realistic |with |an |established |time |period |for |
achievement |of |the |outcomes |that |are |specifically |stated |in |the |outcome |criteria
,Outcome |criteria |includes:
Concrete |descriptions |of |patient |goals, |Expectations |for |behavior, |For |drug |therapy: |our |
expected |outcome |is |safe |and |effective |administration |of |medications
Implementation
Requires |communication/collaboration |with |the |patient, |family, |and |healthcare |provider |team,
|consists |of |initiation |and |completion |of |nursing |actions |as |defined |by |the |Human |Needs |
Statements, |goals, |and |outcome |criteria
With |medication |administration?
you |must |be |knowledgeable |about |your |patient |and |the |medication |you |are |administering, |
and |the |medication |safety |rights
Evaluation
Ongoing |part |of |the |nursing |process, |Includes |monitoring |for |outcomes, |the |patient's |response
|to |drug |therapy |and |any |expected/unexpected |responses, |Documentation |is |important |and |
needs |to |be |clear |and |concise
6 |Rights |+ |3 |rights |of |medication |administration
Right |Client, |Right |medication, |Right |dosage, |Right |route, |Right |time, |Right |documentation |+ |
Right |to |refuse, |Right |indication, |and |Right |Response
, Generic |Name |(nonproprietary)
Usually |much |shorter |and |simpler |than |the |chemical |name. |Patientsoften |only |know |the |
generic |name.
Trade |name |(proprietary)
The |drug |has |a |registered |trademark |and |indicates |it |is |restricted |to |the |owner |of |the |patent |
for |the |drug, |Names |are |usually |shorter |and |easier |to |pronounce |remember |than |generic |
names
what |are |the |benefits |of |using |a |generic |drug?
it |is |cheaper |for |pharmacists |to |go |by |this |name |and |most |patients |know |this |name
Pharmaceutics
The |study |of |how |various |drug |forms |influence |the |way |in |which |the |drug |affects |the |body, |
Dosage |forms |include |enteral, |parenteral, |topical
Do |NOT |crush |drugs |that |have |what?
SR |(slow |released), |SA |(sustained |action), |CR |(controlled |release), |XL |(extended |length), |or |XT |
(extended |time) |they |are |extended-release |formulations
Pharmacokinetics |(4 |steps)
